vs
Essex Property Trust（ESS）与Bio-Techne（TECH）财务数据对比。点击上方公司名可切换其他公司
Essex Property Trust的季度营收约是Bio-Techne的1.6倍（$479.6M vs $295.9M），Essex Property Trust净利率更高（17.9% vs 12.8%，领先5.0%），Essex Property Trust同比增速更快（5.5% vs -6.4%），过去两年Essex Property Trust的营收复合增速更高（6.0% vs 4.2%）
Essex Property Trust是一家公开上市的房地产投资信托企业，重点布局美国西海岸优质不动产市场，核心投资标的为加利福尼亚州及西雅图大都会区的公寓类物业，在长租公寓的投资、运营及管理领域拥有深厚的行业积累与资源优势。
Bio-Techne是美国头部生命科学企业，面向科研、诊断及生物工艺市场需求，研发、生产并销售生命科学试剂、仪器及配套服务，产品及解决方案广泛应用于基础研究、体外诊断、生物医药研发生产等场景，可为相关领域从业者提供可靠的专业工具支持。
ESS vs TECH — 直观对比
营收规模更大
ESS
是对方的1.6倍
$295.9M
营收增速更快
ESS
高出12.0%
-6.4%
净利率更高
ESS
高出5.0%
12.8%
两年增速更快
ESS
近两年复合增速
4.2%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $479.6M | $295.9M |
| 净利润 | $85.7M | $38.0M |
| 毛利率 | 70.0% | 64.6% |
| 营业利润率 | 31.7% | 18.4% |
| 净利率 | 17.9% | 12.8% |
| 营收同比 | 5.5% | -6.4% |
| 净利润同比 | -71.6% | 68.3% |
| 每股收益（稀释后） | $1.24 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESSTECH
| Q4 25 | $479.6M | $295.9M | ||
| Q3 25 | $473.3M | — | ||
| Q2 25 | $469.8M | $317.0M | ||
| Q1 25 | $464.6M | $316.2M | ||
| Q4 24 | $454.5M | $297.0M | ||
| Q3 24 | $450.7M | $289.5M | ||
| Q2 24 | $442.4M | $306.1M | ||
| Q1 24 | $426.9M | $303.4M |
净利润ESSTECH
| Q4 25 | $85.7M | $38.0M | ||
| Q3 25 | $172.7M | — | ||
| Q2 25 | $231.5M | $-17.7M | ||
| Q1 25 | $212.8M | $22.6M | ||
| Q4 24 | $301.7M | $34.9M | ||
| Q3 24 | $125.5M | $33.6M | ||
| Q2 24 | $99.0M | $40.6M | ||
| Q1 24 | $285.1M | $49.1M |
毛利率ESSTECH
| Q4 25 | 70.0% | 64.6% | ||
| Q3 25 | 69.2% | — | ||
| Q2 25 | 70.7% | 62.7% | ||
| Q1 25 | 69.6% | 67.9% | ||
| Q4 24 | 70.0% | 65.3% | ||
| Q3 24 | 69.5% | 63.2% | ||
| Q2 24 | 70.8% | 66.4% | ||
| Q1 24 | 69.7% | 67.4% |
营业利润率ESSTECH
| Q4 25 | 31.7% | 18.4% | ||
| Q3 25 | 44.5% | — | ||
| Q2 25 | 59.5% | -7.5% | ||
| Q1 25 | 55.3% | 12.2% | ||
| Q4 24 | 67.0% | 16.0% | ||
| Q3 24 | 28.6% | 13.8% | ||
| Q2 24 | 31.1% | 15.0% | ||
| Q1 24 | 31.0% | 22.1% |
净利率ESSTECH
| Q4 25 | 17.9% | 12.8% | ||
| Q3 25 | 36.5% | — | ||
| Q2 25 | 49.3% | -5.6% | ||
| Q1 25 | 45.8% | 7.1% | ||
| Q4 24 | 66.4% | 11.7% | ||
| Q3 24 | 27.8% | 11.6% | ||
| Q2 24 | 22.4% | 13.3% | ||
| Q1 24 | 66.8% | 16.2% |
每股收益（稀释后）ESSTECH
| Q4 25 | $1.24 | $0.24 | ||
| Q3 25 | $2.56 | — | ||
| Q2 25 | $3.44 | $-0.11 | ||
| Q1 25 | $3.16 | $0.14 | ||
| Q4 24 | $4.00 | $0.22 | ||
| Q3 24 | $1.84 | $0.21 | ||
| Q2 24 | $1.45 | $0.26 | ||
| Q1 24 | $4.25 | $0.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $76.2M | $172.9M |
| 总债务越低越好 | — | $260.0M |
| 股东权益账面价值 | $5.5B | $2.0B |
| 总资产 | $13.2B | $2.5B |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资ESSTECH
| Q4 25 | $76.2M | $172.9M | ||
| Q3 25 | $66.0M | — | ||
| Q2 25 | $58.7M | $162.2M | ||
| Q1 25 | $98.7M | $140.7M | ||
| Q4 24 | $66.8M | $177.5M | ||
| Q3 24 | $71.3M | $187.5M | ||
| Q2 24 | $55.2M | $152.9M | ||
| Q1 24 | $499.0M | $145.3M |
总债务ESSTECH
| Q4 25 | — | $260.0M | ||
| Q3 25 | $6.4B | — | ||
| Q2 25 | $6.4B | $346.0M | ||
| Q1 25 | $6.8B | $330.0M | ||
| Q4 24 | — | $300.0M | ||
| Q3 24 | $6.4B | $300.0M | ||
| Q2 24 | $6.2B | $319.0M | ||
| Q1 24 | $6.6B | $389.0M |
股东权益ESSTECH
| Q4 25 | $5.5B | $2.0B | ||
| Q3 25 | $5.6B | — | ||
| Q2 25 | $5.6B | $1.9B | ||
| Q1 25 | $5.6B | $2.0B | ||
| Q4 24 | $5.5B | $2.1B | ||
| Q3 24 | $5.4B | $2.1B | ||
| Q2 24 | $5.5B | $2.1B | ||
| Q1 24 | $5.5B | $2.0B |
总资产ESSTECH
| Q4 25 | $13.2B | $2.5B | ||
| Q3 25 | $13.2B | — | ||
| Q2 25 | $13.2B | $2.6B | ||
| Q1 25 | $13.2B | $2.6B | ||
| Q4 24 | $12.9B | $2.7B | ||
| Q3 24 | $12.6B | $2.7B | ||
| Q2 24 | $12.5B | $2.7B | ||
| Q1 24 | $12.9B | $2.7B |
负债/权益比ESSTECH
| Q4 25 | — | 0.13× | ||
| Q3 25 | 1.15× | — | ||
| Q2 25 | 1.14× | 0.18× | ||
| Q1 25 | 1.22× | 0.16× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | 1.18× | 0.14× | ||
| Q2 24 | 1.13× | 0.15× | ||
| Q1 24 | 1.19× | 0.19× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.1B | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 12.53× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ESSTECH
| Q4 25 | $1.1B | — | ||
| Q3 25 | $342.6M | — | ||
| Q2 25 | $216.1M | $98.2M | ||
| Q1 25 | $281.5M | $41.1M | ||
| Q4 24 | $1.1B | $84.3M | ||
| Q3 24 | $316.2M | $63.9M | ||
| Q2 24 | $218.9M | $75.5M | ||
| Q1 24 | $314.9M | $81.0M |
自由现金流ESSTECH
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $93.3M | ||
| Q1 25 | — | $31.0M | ||
| Q4 24 | — | $77.5M | ||
| Q3 24 | — | $54.7M | ||
| Q2 24 | — | $57.5M | ||
| Q1 24 | — | $64.5M |
自由现金流率ESSTECH
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 29.4% | ||
| Q1 25 | — | 9.8% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 18.9% | ||
| Q2 24 | — | 18.8% | ||
| Q1 24 | — | 21.3% |
资本支出强度ESSTECH
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 1.5% | ||
| Q1 25 | — | 3.2% | ||
| Q4 24 | — | 2.3% | ||
| Q3 24 | — | 3.2% | ||
| Q2 24 | — | 5.9% | ||
| Q1 24 | — | 5.4% |
现金转化率ESSTECH
| Q4 25 | 12.53× | — | ||
| Q3 25 | 1.98× | — | ||
| Q2 25 | 0.93× | — | ||
| Q1 25 | 1.32× | 1.82× | ||
| Q4 24 | 3.54× | 2.42× | ||
| Q3 24 | 2.52× | 1.90× | ||
| Q2 24 | 2.21× | 1.86× | ||
| Q1 24 | 1.10× | 1.65× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESS
暂无分部数据
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
